Wednesday, June 10, 2026

Patent intelligence · AR

AR 132581

COMPOSICIÓN INMUNÓGENA ÚTIL PARA LA AUTOADMINISTRACIÓN POR CERDOS

granted A61K 39/ 00 A IA61K 39/ 12 A IA61K/3912A61K/4726
Status granted
Years to expiry 19
Applicant portfolio 21
Patent details — AR 132581
Jurisdiction
AR
Status
granted
Grant date
Jul 16, 2025
Expiration
Jul 11, 2045
CPC classes
A61K 39/ 00 A I, A61K 39/ 12 A I, A61K/3912, A61K/4726
View on Google Patents ↗

Quick answer

AR 132581 (COMPOSICIÓN INMUNÓGENA ÚTIL PARA LA AUTOADMINISTRACIÓN POR CERDOS) is held by BOEHRINGER INGELHEIM VETMEDICA GMBH [DE]. Status: granted. Granted Jul 16, 2025. Expires Jul 11, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 39/ 00 A I, A61K 39/ 12 A I, A61K/3912, A61K/4726, A61K/90056, A61P 31/ 20 A I

More from BOEHRINGER INGELHEIM VETMEDICA GMBH [DE]

Related pharmaceutical patents in our USPTO index.

  1. MX 2025012909

    METHOD FOR INDUCING AN IMMUNE RESPONSE

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Nov 26, 2045

    granted
  2. WO 2025210141

    SYSTÈME D'ADMINISTRATION UTILE POUR L'ADMINISTRATION TOPIQUE D'ARN

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Oct 4, 2045

    granted
  3. US 2025281584

    ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Sep 6, 2045

    granted
  4. US 2025195525

    ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OF SYSTEMIC DISEASES IN CATS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Jun 14, 2045

    granted
  5. WO 2025046413

    VECTEURS DE VIA DE VMN ET LEURS UTILISATIONS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Mar 1, 2045

    granted
  6. WO 2025046414

    VECTEURS DE CDV VIA ET LEURS UTILISATIONS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Mar 1, 2045

    granted
  7. US 2025064917

    HVT AIV VECTORS AND USES THEREOF

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Expires Feb 22, 2045

    granted

Frequently asked questions

What is US patent 132581?

AR 132581 (COMPOSICIÓN INMUNÓGENA ÚTIL PARA LA AUTOADMINISTRACIÓN POR CERDOS) is held by BOEHRINGER INGELHEIM VETMEDICA GMBH [DE]. Status: granted. Granted Jul 16, 2025. Expires Jul 11, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.

Who owns AR 132581?

BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 21 pharmaceutical patents for this assignee.

When does AR 132581 expire?

Our index shows an expiration date of Jul 11, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.